Monthly Archives: November 2017

28 November 2017

Parkwalk closes Opsydia investment

By |November 28th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has made an investment in Opsydia, a spin-out company from the Department of Engineering Science at the University of Oxford, specialising in designing bespoke optical systems and laser fabrication processes for complex and unique ideas.

Perpetuum – Parkwalk closes follow on investment

By |November 21st, 2017|

We have recently closed a follow-on investment in Perpetuum for the Opportunities EIS Fund, alongside existing investors IP Group and ETF.

Perpetuum is a world-leader in vibration harvester-powered wireless sensing systems used to provide information to improve the efficiency, safety and quality of railway operations.

Perpetuum’s technology provides self-powered wireless conditioning monitoring solutions for rail applications and perpetual power for […]

Parkwalk – First Light Fusion Successful Exit

By |November 20th, 2017|

Parkwalk, the leading EIS investor in UK University spin-out companies, is pleased to announce the exit of the majority of its holding in First Light Fusion via a successful sale to Oxford Sciences Innovation.

Parkwalk was one of the initial investors in the company when it was formed in June 2011 and has invested in […]

Parkwalk closes Quantum Motion Technologies investment

By |November 15th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has made an investment in Quantum Motion Technologies, a spin-out company from scientists at University of Oxford and UCL, as part of a Seed investment round of equity funding. The company aims to develop quantum computer architectures based on silicon technology, leveraging CMOS processing […]

Animal Dynamics – Parkwalk closes follow-on investment

By |November 12th, 2017|

We are pleased to have participated in a follow-on financing round in Animal Dynamics Limited, who are developing a portfolio of products derived from research into evolutionary adaptations in flight, swimming, walking, and stealth, where nature has arrived at significant performance optimisations which can be applied to commercial products.

Parkwalk and UCEF III close NeoPhore investment

By |November 6th, 2017|

We are pleased to announce that the University of Cambridge Enterprise Fund III, managed by Parkwalk, and Parkwalk funds have made an investment in NeoPhore, a PhoreMost Ltd spinout, alongside the Cancer Research Technology Pioneer Fund and the University of Cambridge. NeoPhore’s mission is to develop novel small molecule therapies to treat cancer by […]

Parkwalk closes Arvia investment

By |November 3rd, 2017|

We are delighted to announce that Parkwalk has made a follow-on investment into Arvia Technology from the Opportunities EIS Fund.

Arvia is exploiting a disruptive new technology for the treatment of organic and microbial wastes in water.  Spun-out from the University of Manchester, Arvia has received a plethora of major sustainability and technology innovation awards over the last five […]

Parkwalk and UOIF III close MoA investment

By |November 2nd, 2017|

We are pleased to announce that the University of Oxford Innovation Fund III, managed by Parkwalk, and the Parkwalk Opportunities EIS Fund have made an investment in MoA Technology, a spin-out from the University of Oxford. The company is developing novel technology with applications in plant protection products.